Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma

International Journal of Cancer

Volumn 84, Issue 3, 1999, Pages 315-320

  Fujieda, Shigeharu ^a   Inuzuka, Manabu ^a   Tanaka, Nobuyuki ^a   Sunaga, Hiroshi ^a   Fan, Guo Kang ^a   Ito, Toshihisa ^a   Sugimoto, Chizuru ^a   Tsuzuki, Hideaki ^a   Saito, Hitoshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P27; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL CYCLE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ONCOGENE C MYC; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS;

EID: 0033060097     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990621)84:3<315::AID-IJC20>3.0.CO;2-U     Document Type: Article

References (26)

1. BORNER, C., Diminished cell proliferation associated with the death-protective activity of Bcl-2. J. biol. Chem., 271, 12695-12698 (1996).
2. BRANDY, H.J.M., GIL-GÕMEX, G., KIRBERG, J. and BERNS, A.J.M., Baxa perturbs T cell development and affects cell cycle entry of T cells. EMBO J., 15, 6991-7001 (1996).
3. Kipl protein: prognostic implications in primary breast cancer. Nature (Med.), 3, 227-230 (1997).
4. Kipl protein in human esophageal cancer cell lines that over-express cyclin D1. Carcinogenesis, 18, 1139-1148 (1997).
5. DREXLER, H.C.A., Activation of the cell death program by inhibition of proteasome function. Proc. nat. Acad. Sci. (Wash.), 94, 855-860 (1997).
6. EVAN, G.I., WYLLIE, A.H., GILBERT, C.S., LITTLEWOOD, T.D., LAND, H., BROOKS, M., WATERS, C.M., PENN, L.Z. and HANCOCK, D.C., Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69, 119-128 (1992).
7. FUJIEDA, S., SUNAGA, H., TSUZUKI, H., TANAKA, N. and SAITO, H., Expression of platelet-derived endothelial cell growth factor in oral and oropahryngeal carcinoma. Clin. Cancer Res., 4, 1583-1590 (1998).
8. Kipl, inhibits growth, and enhances apoptosis. Cell Growth Differentiation, 7, 699-710 (1996).
9. HOCKENBERY, D., NUÑEZ, G., MILLIMAN, C., SCHREIBER, R.D. and KORSMEYER, S.J., Bcl-2 in an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348, 334-336 (1990).
10. KATAYOSE, Y., KIM, M., RAKKAR, A.N.S., LI, Z., COWAN, K.H. and SETH, P., Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res., 57, 5441-5445 (1997).
11. LIN, J.K. and CHOU, C.K., In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1. Cancer Res., 52, 385-388 (1992).
12. LODA, M., CUKOR, B., TAM, S.W., LAVIN, P., FIORENTINO, M., DRAETTA, G.F., JESSUP, J.M. and PAGANO, M., Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature (Med.), 3, 231-234 (1997).
13. LU, C. and TANIGAWA, N., Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma. Cancer Res., 57, 221-224 (1997).
14. MORI, M., MIMORI, K., SHIRAISHI, T., TANAKA, S., UEO, H., SUGIMACHI, K. and AKIYOSHI, T., p27 expression and gastric carcinoma. Nature (Med.), 3, 593 (1997).
15. OLTVAI, Z.N., MILLIMAN, C.L. and KORSMEYER, S.J., Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 609-619 (1993).
16. PAGANO, M., TAM, S.W., THEODORAS, A.M., BEER-ROMERO, P., SAL, G.D., CHAU, V., YEW, P.R., DRAETTA, G.F. and ROLFE, M., Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science, 269, 682-685 (1995).
17. PELED, A., ZIPORI, D. and ROTTER, V., Cooperation between p53-dependent and p53-independent apoptotic pathways in myeloid cells. Cancer Res., 56, 2148-2156 (1996).
18. Kipl, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Develop., 8, 9-22 (1994a).
19. Kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66 (1994b).
20. Kipl: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res., 55, 1211-1214 (1995).
21. Kipl and cyclin E, alone and in combination, correlates with survival in young breast cancer patients. Nature (Med.), 3, 222-225 (1997).
22. II250 mutant cells arrest in G1 at the restrictive temperature. Genes Cells, 1, 687-705 (1996).
23. SOLDATENKOV, V.A. and DRITSCHILO, A., Apoptosis of Ewing's sarcoma cells is accompanied by accumulation of ubiquitinated proteins. Cancer Res., 57, 3881-3885 (1997).
24. TOYOSHIMA, H. and HUNTER, T., p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78, 67-74 (1994).
25. YIN, C., KNUDSON, M., KORSMEYER, S.J. and DYKE, T.V., Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature (Lond.), 385, 637-640 (1997).
26. + cells within human head and neck squamous cell carcinomas. J. Immunol., 159, 990-996 (1997).